Safe and Effective Pharmacological Tobacco Cessation Supports
for Individuals with Behavioral Health Conditions
Tuesday, November 28, 2017
2:00 - 3:30pm (1.5hrs) EST
Only about 1 in 4 mental health treatment facilities offer tobacco cessation services, and even fewer utilize pharmacological supports. This presents many organizations with ample opportunities to adopt programs and best practices for tobacco cessation treatment with clients.
Do you know which medications are the safest and most effective for enhancing quit attempts with behavioral health populations? Join the National Behavioral Health Network and SAMSHA for a co-hosted webinar, Safe and Effective Pharmacological Tobacco Cessation Supports for Individuals with Behavioral Health Conditions on Tuesday, Nov. 28, for a presentation on new research and recommendations around Varenicline, Bupropion, and other cessation supports to assist your clients who want to stop using tobacco. You will also learn about the FDA removal of boxed warnings in their labeling of medications, new safety and efficacy research around medications, and best practices in overcoming challenges related to tobacco cessation services.
Expert Presenters include:
- Dr. Anita Everett, Chief Medical Officer, Substance Abuse & Mental Health Services Administration
- Dr. Jill Williams, Professor of Psychiatry and Director of the Division of Addiction Psychiatry, Rutgers University-Robert Wood Johnson Medical School
- Dr. Marc Steinberg, Associate Professor of Psychiatry and Associate Director of the Division of Addiction Psychiatry, Rutgers University-Robert Wood Johnson Medical School
- Patricia Dooley, Director, CHOICES, Rutgers University